Efficacy of @entity1160 -Enriched Nutrition Support for XXXX With Severe Acute Pancreatitis: A Meta-analysis.

@entity1 @entity7647 @entity1160 @entity656
UNASSIGNED: Background: Plasma @entity1160 ( @entity7647 ) level has been negatively correlated with the severity of @entity656 ( @entity656 ). Although @entity7647 is widely used today, the results of individual randomized controlled trials of @entity7647 -enriched nutrition support for @entity1 with @entity656 are conflicting. Methods: PubMed, EMBASE, HighWire, Cochrane Central Register of Controlled Trials, Wanfang, China Journals Full-Text Database, and the Chinese Biomedical Literature Database were searched. Literature published before June 2014 was searched. Randomized controlled trials investigating the comparison of conventional and @entity7647 -enriched nutrition support were included; a random effect model using Rev @entity1 5.2 software was chosen to complete this meta-analysis. The count data were analyzed using the risk ratio (RR) and 95% confidence interval (CI), and the measurement data were analyzed using the standard mean difference or weighted mean difference and 95% CI. Heterogeneity analyses were conducted by I(2) test; publication bias analyses were conducted by Begg test. Results: Ten studies were eventually chosen for analysis, including 218 @entity1 who received conventional methods (control group) and 215 @entity1 who received @entity7647 -enriched nutrition support (experimental group). Compared with the control group, @entity7647 is helpful in elevating the albumin level, decreasing C-reaction protein (standard mean difference = 1.01, -1.89; 95% CI: 0.50 to 1.51, -3.23 to -0.56; P < .05), decreasing the incidence of infectious complication and mortality (RR = 0.62, 0.36; 95% CI: 0.46 to 0.83, 0.16 to 0.83; P < .05), and shortening the hospital stay length (weighted mean difference [WMD] = -3.89; 95% CI: -4.98 to -2.81; P < .05) without increasing expenses (WMD = -0.16; 95% CI: -1.34 to 1.02; P > .05). Intravenous infusion manifested more advantages by decreasing the incidence of infectious complications and mortality. Conclusions: @entity7647 -enriched nutrition support is superior to conventional methods for @entity656 , and intravenous infusion may be a better choice for drug administration.
